Back to Search Start Over

Treatment of chronic hepatitis C virus infection in Rwanda with ledipasvir–sofosbuvir (SHARED): a single-arm trial

Authors :
Gupta, Neil
Mbituyumuremyi, Aimable
Kabahizi, Jules
Ntaganda, Fabien
Muvunyi, Claude Mambo
Shumbusho, Fabienne
Musabeyezu, Emmanuel
Mukabatsinda, Constance
Ntirenganya, Cyprien
Van Nuil, Jennifer Ilo
Kateera, Fredrick
Camus, Gregory
Damascene, Makuza Jean
Nsanzimana, Sabin
Mukherjee, Joia
Grant, Philip M
Source :
The Lancet Gastroenterology & Hepatology; February 2019, Vol. 4 Issue: 2 p119-126, 8p
Publication Year :
2019

Abstract

Limited treatment data are available for hepatitis C virus (HCV) in sub-Saharan Africa, especially for genotype 4. Our objective was to establish the safety and efficacy of ledipasvir–sofosbuvir for chronic HCV genotype 1 or 4 infection in adults in Rwanda.

Details

Language :
English
ISSN :
24681253
Volume :
4
Issue :
2
Database :
Supplemental Index
Journal :
The Lancet Gastroenterology & Hepatology
Publication Type :
Periodical
Accession number :
ejs48015848
Full Text :
https://doi.org/10.1016/S2468-1253(18)30382-0